# Towa Pharmaceutical Europe, S.L. – FDA Inspection, Mar 31, 2017

Source: https://www.keypedia.com/records/fda_inspections/towa-pharmaceutical-europe-sl/9948e85f-5b91-4a1e-998a-3e96ca2da81e
Source feed: FDA_Inspections

> FDA inspection 1018727 of Towa Pharmaceutical Europe, S.L., March 31, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1018727
- Company Name: Towa Pharmaceutical Europe, S.L.
- Inspection Date: 2017-03-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1180157 - 2022-09-09
- FDA Inspection 1100280 - 2019-01-18
- FDA Inspection 917425 - 2015-02-13
- FDA Inspection 835225 - 2013-05-10
- FDA Inspection 658164 - 2010-02-19

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/joey-v-quitania/faae874f-94ea-4b63-89d1-649e60726f6f)

Company: https://www.keypedia.com/companies/towa-pharmaceutical-europe-sl/731d0b47-ce02-4781-8582-7090b456c5fe

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c